Opportunities in biotechnology

Kevan M.A. Gartland, Jill S. Gartland

Research output: Contribution to journalArticle

46 Downloads (Pure)

Abstract

Strategies for biotechnology must take account of opportunities for research, innovation and business growth. At a regional level, public-private collaborations provide potential for such growth and the creation of centres of excellence. By considering recent progress in areas such as genomics, healthcare diagnostics, synthetic biology, gene editing and bio-digital technologies, opportunities for smart, strategic and specialised investment are discussed. These opportunities often involve convergent or disruptive technologies, combining for example elements of pharma-science, molecular biology, bioinformatics and novel device development to enhance biotechnology and the life sciences. Analytical applications use novel devices in mobile health, predictive diagnostics and stratified medicine. Synthetic biology provides opportunities for new product development and increased efficiency for existing processes. Successful centres of excellence should promote public-private business partnerships, clustering and global collaborations based on excellence, smart strategies and innovation if they are to remain sustainable in the longer term.
Original languageEnglish
Pages (from-to)38-45
Number of pages8
JournalJournal of Biotechnology
Volume282
Early online date8 Jun 2018
DOIs
Publication statusPublished - Sep 2018

Fingerprint

Synthetic Biology
Biotechnology
Innovation
Public-Private Sector Partnerships
Synthetic Genes
Technology
Equipment and Supplies
Molecular biology
Biological Science Disciplines
Telemedicine
Bioinformatics
Growth
Genomics
Computational Biology
Product development
Medicine
Cluster Analysis
Molecular Biology
Industry
Genes

Keywords

  • biotechnology
  • research and innovation
  • genomics

Cite this

Gartland, Kevan M.A. ; Gartland, Jill S. / Opportunities in biotechnology. In: Journal of Biotechnology. 2018 ; Vol. 282. pp. 38-45.
@article{28382365d65543c3970e53912de06a8a,
title = "Opportunities in biotechnology",
abstract = "Strategies for biotechnology must take account of opportunities for research, innovation and business growth. At a regional level, public-private collaborations provide potential for such growth and the creation of centres of excellence. By considering recent progress in areas such as genomics, healthcare diagnostics, synthetic biology, gene editing and bio-digital technologies, opportunities for smart, strategic and specialised investment are discussed. These opportunities often involve convergent or disruptive technologies, combining for example elements of pharma-science, molecular biology, bioinformatics and novel device development to enhance biotechnology and the life sciences. Analytical applications use novel devices in mobile health, predictive diagnostics and stratified medicine. Synthetic biology provides opportunities for new product development and increased efficiency for existing processes. Successful centres of excellence should promote public-private business partnerships, clustering and global collaborations based on excellence, smart strategies and innovation if they are to remain sustainable in the longer term.",
keywords = "biotechnology, research and innovation, genomics",
author = "Gartland, {Kevan M.A.} and Gartland, {Jill S.}",
note = "Acceptance from webpage AAM: 12m embargo",
year = "2018",
month = "9",
doi = "10.1016/j.jbiotec.2018.06.303",
language = "English",
volume = "282",
pages = "38--45",
journal = "Journal of Biotechnology",
issn = "0168-1656",
publisher = "Elsevier B.V.",

}

Opportunities in biotechnology. / Gartland, Kevan M.A.; Gartland, Jill S.

In: Journal of Biotechnology, Vol. 282, 09.2018, p. 38-45.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Opportunities in biotechnology

AU - Gartland, Kevan M.A.

AU - Gartland, Jill S.

N1 - Acceptance from webpage AAM: 12m embargo

PY - 2018/9

Y1 - 2018/9

N2 - Strategies for biotechnology must take account of opportunities for research, innovation and business growth. At a regional level, public-private collaborations provide potential for such growth and the creation of centres of excellence. By considering recent progress in areas such as genomics, healthcare diagnostics, synthetic biology, gene editing and bio-digital technologies, opportunities for smart, strategic and specialised investment are discussed. These opportunities often involve convergent or disruptive technologies, combining for example elements of pharma-science, molecular biology, bioinformatics and novel device development to enhance biotechnology and the life sciences. Analytical applications use novel devices in mobile health, predictive diagnostics and stratified medicine. Synthetic biology provides opportunities for new product development and increased efficiency for existing processes. Successful centres of excellence should promote public-private business partnerships, clustering and global collaborations based on excellence, smart strategies and innovation if they are to remain sustainable in the longer term.

AB - Strategies for biotechnology must take account of opportunities for research, innovation and business growth. At a regional level, public-private collaborations provide potential for such growth and the creation of centres of excellence. By considering recent progress in areas such as genomics, healthcare diagnostics, synthetic biology, gene editing and bio-digital technologies, opportunities for smart, strategic and specialised investment are discussed. These opportunities often involve convergent or disruptive technologies, combining for example elements of pharma-science, molecular biology, bioinformatics and novel device development to enhance biotechnology and the life sciences. Analytical applications use novel devices in mobile health, predictive diagnostics and stratified medicine. Synthetic biology provides opportunities for new product development and increased efficiency for existing processes. Successful centres of excellence should promote public-private business partnerships, clustering and global collaborations based on excellence, smart strategies and innovation if they are to remain sustainable in the longer term.

KW - biotechnology

KW - research and innovation

KW - genomics

U2 - 10.1016/j.jbiotec.2018.06.303

DO - 10.1016/j.jbiotec.2018.06.303

M3 - Article

VL - 282

SP - 38

EP - 45

JO - Journal of Biotechnology

JF - Journal of Biotechnology

SN - 0168-1656

ER -